RightFit Trial Directory

Breast Cancer clinical trials in Durham, NC

21 recruiting breast cancer studies with a site in Durham, NC.

All trials in Durham, NC · All Breast Cancer trials

RecruitingPhase 3NCT07391774

Testing Whether Hormone Therapy With Ribociclib is as Effective as Chemotherapy Followed by Hormone Therapy With Ribociclib for the Treatment of High Anatomic Stage Breast Cancer With Low Recurrence Risk, The RxFINE-Low Trial

Sponsor: National Cancer Institute (NCI)

Cary, NC · Clinton, NC · Durham, NC · +200 more sites

RecruitingPhase 1NCT06120283

BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast Cancer and Other Advanced Solid Tumors

Sponsor: BeOne Medicines

Durham, NC · +8 more sites

RecruitingPhase 3NCT06790693

A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer

Sponsor: Hoffmann-La Roche

Charlotte, NC · Durham, NC · Winston-Salem, NC · +59 more sites

RecruitingPhase 1NCT06840886

A Study of PHST001 in Advanced Solid Tumors

Sponsor: Pheast Therapeutics

Durham, NC · +19 more sites

RecruitingPhase 1 / Phase 2NCT07488676

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Sponsor: Astellas Pharma Global Development, Inc.

Durham, NC · +17 more sites

RecruitingPhase 3NCT06492616

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

Sponsor: Stemline Therapeutics, Inc.

Durham, NC · Fayetteville, NC · Greensboro, NC · +173 more sites

RecruitingNot applicableNCT06983691

Patient Navigation for HER2+ Metastatic Breast Cancer Patients Treated With Tucatinib

Sponsor: Duke University

Durham, NC

RecruitingPhase 2NCT05846789

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

Sponsor: Kathy Miller

Durham, NC · +6 more sites

RecruitingPhase 3NCT05879926

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Sponsor: NRG Oncology

Albemarle, NC · Asheboro, NC · +1223 more sites

RecruitingPhase 3NCT05812807

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Sponsor: Alliance for Clinical Trials in Oncology

Albemarle, NC · Asheboro, NC · +825 more sites

RecruitingNot applicableNCT06658912

Planning Grant for TOPS for Breast Cancer Survivors

Sponsor: Duke University

Durham, NC

RecruitingNot applicableNCT07335354

A Study of a Decision Tool for People Considering Breast Reconstruction Surgery

Sponsor: Memorial Sloan Kettering Cancer Center

Durham, NC · +7 more sites

RecruitingPhase 3NCT05696626

Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation

Sponsor: LeonaBio

Durham, NC · +35 more sites

RecruitingPhase 1NCT05076760

MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors

Sponsor: Memgen, Inc.

Durham, NC · +1 more sites

RecruitingNot applicableNCT06555588

Engage Psychosocial Intervention for Cancer Symptoms

Sponsor: Duke University

Durham, NC

RecruitingPhase 1NCT06778863

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Sponsor: Clasp Therapeutics, Inc.

Durham, NC · +20 more sites

RecruitingPhase 3NCT06435429

A Study Comparing the Efficacy and Safety of Zanidatamab to Trastuzumab, Each in Combination With Physician's Choice Chemotherapy, for the Treatment of Participants With Metastatic HER2-positive Breast Cancer

Sponsor: Jazz Pharmaceuticals

Asheville, NC · Durham, NC · Morrisville, NC · +45 more sites

RecruitingPhase 1NCT04389281

X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma

Sponsor: Immunolight, LLC

Charlotte, NC · Durham, NC · +2 more sites

RecruitingNot applicableNCT06371768

Symptom Management and Transitioning to Engagement With Post-treatment Care for Adolescent and Young Adult Cancer Survivors

Sponsor: Duke University

Durham, NC

Not yet recruitingPhase 3NCT07723469

Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing Breast-Conserving Surgery

Sponsor: SURGE Therapeutics

Durham, NC · +2 more sites

Not yet recruitingPhase not listedNCT05370300

SNAPS Breast Cancer Patient Study Breast Cancer Patients

Sponsor: Immunis.AI

Durham, NC

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.